// App-Quantinova.ai

4161 : Bortezomib enhances expression of effector molecules in antitumor CD8+ T lymphocytes by modulating Notch-NF-kB-miR-155 crosstalk

Researchers

Presenter

  • Ariana N. Renrick

Principal Investigators

  • Menaka C. Thounaojam

  • Duafalia F. Dudimah

  • Portia Thomas

  • Samuel T. Pellom

  • Roman V. Uzhachenko

  • Anil Shanker

Medical Centers

  • Meharry Medical College, Nashville, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • Hes family bHLH transcription factor 1

Drug/Treatment

  • Bortezomib

  • miR155

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved